Advanced search
Publication Cover
The European Journal of Contraception & Reproductive Health Care Volume 5, 2000 - Issue 4
Submit an article Journal homepage
468
Views
100
CrossRef citations to date
0
Altmetric
Review Article

The effects of age, body mass index, smoking and general health on the risk of venous thromboembolism in users of combined oral contraceptives

Mrs A. L. Nightingale Department of Pharmacoepidemiology and Primary Care, Postgraduate Medical School, University of Surrey, Guildford, UK
,
R. A. Lawrenson Department of Pharmacoepidemiology and Primary Care, Postgraduate Medical School, University of Surrey, Guildford, UK
,
E. L. Simpson Department of Pharmacoepidemiology and Primary Care, Postgraduate Medical School, University of Surrey, Guildford, UK
,
T. J. Williams Department of Pharmacoepidemiology and Primary Care, Postgraduate Medical School, University of Surrey, Guildford, UK
,
K. D. MacRae Department of Pharmacoepidemiology and Primary Care, Postgraduate Medical School, University of Surrey, Guildford, UK
&
R. D. T. Farmer Department of Pharmacoepidemiology and Primary Care, Postgraduate Medical School, University of Surrey, Guildford, UK
Pages 265-274 | Accepted 06 Nov 2000, Published online: 06 Jul 2009

REFERENCES

  • Bloemenkamp K W, Rosendaal F R, Helmerholst F M, et al. Enhancement by factor V Leiden mutation of risk of deep vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593–6
  • Vandenbroucke J P, Koster T, Briet E, et al. Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453–7
  • British National Formulary. The British Medical Association and the Royal Pharmaceutical Society of Great Britain. March, 1999, Issue 37
  • Farley T MM, Meirik O, Chang C L, et al. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Effects of different progestagens in low estrogen oral contraceptives on venous thromboembolic disease. Lancet 1995; 346: 1582–8
  • Jick H, Jick S S, Gurewich V, et al. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589–93
  • Poulter N R, Chang C L, Farley T MM, et al. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. Lancet 1995; 346: 1575–82
  • Spitzer W O, Lewis M A, Heinemann L A, et al. Transnational Research Group on Oral Contraceptives and the Health of Young Women. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Br Med J 1996; 312: 83–8
  • Petitti D, Wingerd J, Pellegrin F, Ramcharan S. Oral contraceptives, smoking and other factors in relation to risk of venous thromboembolic disease. Am J Epidemiol 1978; 108: 480–5
  • Farmer R DT, Lawrenson R A, Todd J-C, et al. A comparison of the risk of venous thromboembolic disease in association with different combined oral contraceptives. Br J Clin Pharmacol 2000; 49: 591–6
  • Todd J-C, Lawrenson R A, Farmer R DT, Williams T J. Venous thromboembolic disease and combined oral contraceptives – a re-analysis of the MediPlus database. Hum Reprod 1999; 14: 101–6
  • StataCorp. STATA Statistical Software Release 5.0. Stata Corporation, College Station, TX 1997
  • Petitti D B. Monographs in Epidemiology and Biostatics Volume 24: Meta-Analysis, Decision Analysis and Cost-Effectiveness Analysis. Oxford University Press, Oxford 1994; 106–11
  • Lawrenson R A, Todd J-C, Williams T J, Farmer R DT. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 2000; 49: 591–6
  • MacDonald T M, Evans J MM, Sullivan F, McMahon A D. Principles of epidemiological research on drug effects. Lancet 1999; 353: 502
  • Pini M, Scoditti U, Caliumi F, et al. Risk of venous thromboembolism and stroke associated with oral contraceptives. Role of congenital thrombophilias. Recenti Progressi in Medicina 1996; 87: 331–7
  • Gertsman B B, Piper J M, Freiman J P, et al. Oral contraceptive oestrogen and progestin potencies and the incidence of deep venous thromboembolism. Int Epidemiol 1990; 19: 931–6
  • Vessey M, Mant D, Smith A, Yeates D. Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br Med J Clin Res Edn 1986; 292: 526
  • Silverstein M D, Heit J A, Mohr D N, et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism. A 25-year population-based study. Arch Intern Med 1998; 158: 585–93
  • Lidegaard O. Thrombotic diseases in young women and the influence of oral contraceptives. Am J Obstet Gynecol 1998; 179: S62–7
  • World Health Organization Scientific Group on Cardiovascular Disease and Steroid Hormone Contraception. Cardiovascular Disease and Steroid Hormone Contraception: Report of a WHO Scientific Group. WHO, GenevaSwitzerland 1997, Technical Report Series 877
  • ABPI compendium of datasheets and summaries of product characteristics. 1996–1997 edn. Datapharm Publications Ltd, London
  • Mayor S. Department of Health changes advice on third generation pills. Br Med J 1999; 318: 1026
  • Farmer R DT, Lawrenson R A, Todd J-C, et al. Oral contraceptives and venous thromboembolic disease. Analysis of the UK General Practice Research Database and the UK MediPlus Database. Hum Reprod Update 1999; 5: 688–706

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.